CRISPR Therapeutics AG
CRSPNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$56.38
Day High
$56.39
Day Low
$54.27
Prev. Close
$56.38
VolumeShares traded today.
1.87M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$5.42B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-9.05
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$78.48
52W LowLowest price over the past 52 weeks.
$36.08
50D MAAverage closing price over the last 50 trading days.
$51.47
200D MAAverage closing price over the last 200 trading days.
$55.72
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+12.6%1M
+10.8%6M
+4.9%YTD
+4.5%1Y
+54.8%About
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award (FOYA) award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration (FDA) in December 2023.
crisprtx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade CRSP
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.